Safety, efficacy and pharmacokinetics of palivizumab in off-label neonates, infants, and young children at risk for serious respiratory syncytial virus infection: a multicenter phase II clinical trial.
Lancet Reg Health West Pac
; 39: 100847, 2023 Oct.
Article
in En
| MEDLINE
| ID: mdl-37554997
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Lancet Reg Health West Pac
Year:
2023
Document type:
Article
Affiliation country:
Japón
Country of publication:
Reino Unido